HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makoto Samukawa Selected Research

galactocerebroside

1/2015[A case of pure-sensory-type Guillain-Barré syndrome with galactocerebroside antibody].
2/2014Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
12/2012Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Makoto Samukawa Research Topics

Disease

3Guillain-Barre Syndrome
12/2016 - 02/2014
3Polyneuropathies (Polyneuropathy)
02/2015 - 05/2013
2Parkinson Disease (Parkinson's Disease)
01/2020 - 03/2018
2Multiple System Atrophy
03/2018 - 12/2011
2Encephalitis (Encephalitis, Rasmussen)
01/2016 - 01/2013
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
08/2021
1Cerebellar Ataxia (Dysmetria)
08/2021
1Neutral Lipid Storage Disease with Myopathy
01/2020
1Anti-N-Methyl-D-Aspartate Receptor Encephalitis
05/2019
1Autoimmune Diseases of the Nervous System
05/2019
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
03/2018
1Central Nervous System Diseases (CNS Diseases)
03/2017
1Mycoplasma Pneumonia
03/2017
1Ophthalmoplegia (External Ophthalmoplegia)
12/2016
1Exanthema (Rash)
01/2016
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2016
1Infections
09/2014
1Peripheral Nervous System Diseases (PNS Diseases)
09/2014
1Ataxia (Dyssynergia)
05/2013
1Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
05/2013
1Immune System Diseases (Immune Disorders)
01/2013
1Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
12/2012
1Disease Progression
09/2012

Drug/Important Bio-Agent (IBA)

6AntibodiesIBA
03/2017 - 12/2012
5GlycolipidsIBA
03/2017 - 12/2012
3galactocerebrosideIBA
01/2015 - 12/2012
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2019 - 01/2013
2Immunoglobulin M (IgM)IBA
03/2017 - 09/2014
2GangliosidesIBA
12/2016 - 05/2013
2AntigensIBA
12/2016 - 05/2013
1DNA (Deoxyribonucleic Acid)IBA
08/2021
1rasagiline (Azilect)FDA Link
01/2020
1Triglycerides (Triacylglycerol)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
03/2018
1Protein Deglycase DJ-1IBA
03/2018
1Immunoglobulin G (IgG)IBA
12/2016
1mogamulizumabIBA
01/2016
1Monoclonal AntibodiesIBA
01/2016
1Myelin-Associated GlycoproteinIBA
02/2015
1SteroidsIBA
12/2012
1Intravenous Immunoglobulins (IVIG)FDA Link
12/2012
11-bromopropane (propyl bromide)IBA
09/2012
1Vasopressins (Vasopressin)IBA
12/2011

Therapy/Procedure

1Therapeutics
12/2012